Schedule 13G ownership disclosure
ESSA PHARMA INC
Security class unavailable · CUSIP: 29668H708
Event date: 2021-08-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 10.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-21-248897
- Form type
- SC 13G
- Filer
- BB BIOTECH AG
- CIK
- CIK 924223
- Filed
- Aug 17, 2021
- Reporting period
- Aug 16, 2021
- Description
- Schedule 13G beneficial ownership